No Detail Found!

Seroprevalence and Risk Factors of Hepatitis B Virus among Blood Donors in District Charsadda Khyber Pakhtunkhwa Pakistan.

Author(s)
Muhammad Israr College of life science, Hebei Normal University Shijiazhuang, Hebei PR-China
Fawad Ali ICS, University of Peshawar, Peshawar, KP-Pakistan
Murtala Muhammad College of life science, Hebei Normal University Shijiazhuang, Hebei PR-China
Noor Bahadar School of Life Sciences, Northeast Normal University Changchun, Jilin PR-China
Abstract
Hepatitis B Virus (HBV) is a serious worldwide public health issue both in underdeveloped and developed countries. About two billion individuals were infected by HBV globally, of which 400 million were chronic HBV carrier. The aim of this retrospective study was to investigate the seroprevalence and some possible risk factors of hepatitis B virus infection among male blood donors in district Charsadda, Khyber Pakhtunkhwa Pakistan. A total of 460 male blood donors with age range 15-55 years were screened for HBsAg by Immunochromatographic technique (ICT) and 3rd generation enzyme-linked immunosorbent assay (ELISA). Out of 460 samples, 11(2.39%) were found positive for HBsAg by ICT, and 13(2.82%) were HBsAg positive by ELISA. The mean seroprevalence of HBV from both ICT and ELISA was 2.60%. The highest seroprevalence (46.15%) was observed among the donor groups with age range of 21-30 years followed by (30.76%) among 15-20 years, (15.38%) among 31-40 years and the lowest seroprevalence (7.69%) among 41-55 years. Blood transfusion (30.76%) was the most apparent influencing risk factor for HBV followed by dental treatment (23.07%), Sexual partner positive for HBV infection (15.38%), surgery and shave by the barbers (7.69%) for each and unknown reason (15.38%).
Publication Details
Page(s) 669-675
Published Journal: Pure and Applied Biology, Volume: 6, Issue: 2, Year: 2017

Request the full text from PASTIC

Keywords
Elisa, Risk Factors, Blood donors, ICT, Hepatitis B virus
References
JoseAMM,CarlaLAA,GloriaMC, .,of HBV DNA. J Virol Meth 103 201 -212
GM, 2012.Prevalence and resistance, -
Mexico,KhanF,AkbarH,IdreesM,KhanH, .,Annal Hepatol 11 47 -51
MahoneyFJ, 1999.,Update on diagnosis, 11 176 -
.B virus infection,Clin Microbiol Rev 12 -
BukhariSM,KhatoonN,IqbalA, ., 366 -
S , Shafqat,S , Lone,A & Naveed,IA, 1999., -
.,Mayo hospital Lahore. Biomedica 15 88 -
FairleyCK,ReadTR, 2012., -
.,Curr Opin Infect Dis 25 -
BuddebergF,SchimmerBB,SpahnDR, ., 11 -
2008.Transfusion-transmissible, -
HughesRA, 2000.Drug injectors and,An 22 12 -17
KhanNU,SiddiqueL,AliI,IqbalA, .,Addict Res 6 13 -30
MunirI,RashidF, 2010., -
2011.,Afr J Biotechnol 9 14 -6166
AwanZ,IdreesM,AminI,ButtS, .stumbling in RI's hepatitis fight, -
M , Lal A,SaleemS,RauffB, 2010., -
Pakistan,AlamMM,ZaidiSZ,MalikSA, .,Infect Gen Evol 10 16 -1246
2007b.JA (,Molecular epidemiology of -
AlamMM,ZaidiSZ,ShaukatS, .,BMC Infect 7 115 -
S, 2007.Common Genotype of hepatitis, -
PillonelJ,SauraC, .Courouce AM,of Pakistan. Virol J 4 63 -
1998.Prevalence of HIV, HTLV, -
1992., 1996 -
LauDTY,MaH,LemonSM,DooM, ., 5 19 -312
ParkY,Hoofnagle JH, 2003., -
KhattakMF,SalamatN,BhattiFA, .,Hepatitis 10 20 -334
QureshiTZ, 2002., -
AttaullahS,KhanS,KhanJ, 2012.,in Northern Pakistan. JPMA 52 398 -
FayyazM,KhanMA,ChaudharyGM, .,J Transl Med 10 20 -
QaziMA,AhmedG, 2006., -
.in blood donors,Prof Med J 13 632 -
MujeebSA,PearceMS, 2008., -
MumtazS,RehmanM,MuzaffarM, ., 8 43 -
HassanM,IqbalW, 2002., -
Rawalpindi,IshaqM,AliSS,KarimN,UmraniNI, .,Pak J Med Res 41 25 -3
Hassan N, 2007., -
FayyazKM,AliS,KhanAA, .,Coll 12 26 -101
2002.Hepatitis B carriers; diagnosis, -
Bahawalpur, .,Professional Med J 9 186 -
TestedSamples,AbdelbagiM,HadyaN,TayebA, ., 28 -
RehmanFU,JehangirK,ZahidF, .,Virol J 6 146 -
P , Ahmad,R & Shandana S, 2011., -
0

Citations

0

Downloads

41

Views